RHAZES PHARMA LIMITED
Significant control: Mehraan Sattar (25–50%), Hussain Abdeh (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Rhazes Pharma Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Rhazes Pharma Limited sell?
Registered activity: Manufacture of basic pharmaceutical products (SIC 21100). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
RHAZES PHARMA LIMITED is an active private limited company (company number 14233328) incorporated on 13 July 2022, registered in Manchester. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest small accounts cover the period ending 31 July 2025, showing net assets of £4,950 and cash of £194, with 3 employees on average. Net assets rose 352% on the prior period (−£1,966).
By net assets it sits in the upper half of 661 comparable companies in the UK (median £265, upper quartile £89k).
Ownership and control
- Mr Mehraan Sattar
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Mr Hussain Abdeh
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 13 July 20224 yrs ago
- Next accounts due
- 30 April 2027in 188 days
- Confirmation statement due
- 27 July 2027in 276 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 21100
- Manufacture of basic pharmaceutical products
- SIC 46460
- Wholesale of pharmaceutical goods
- SIC 47730
- Dispensing chemist in specialised stores
- SIC 86900
- Other human health activities
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 July 2025 | £4,950 | £194 | £36k | £3,373 | — | — | 3 |
| 31 July 2024 | −£1,966 | £1,688 | £5,660 | £480 | — | — | 3 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £4,950 at 31 July 2025
- Net assets up 10% or more on the prior period+351.8% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 10.83
- Incorporated two to five years agoIncorporated 13 July 2022
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 276 days
- Next accounts duein 188 days
- Accounts period endNet assets £4,950 · small accounts
- Accounts period endNet liabilities £1,966 · small accounts
- Incorporated
Similar companies in Manchester
- HASSTAM LTDStockport · inc. Jun 2022
- COMANCHE BIOPHARMA (UK) LIMITEDAltrincham · inc. Sept 2022
- BP MED LIMITEDManchester · inc. Nov 2022
- THERAGENIX LTDManchester · inc. Dec 2022
- AURA PVT LTDSalford · inc. Feb 2022
- IOVANCE BIOTHERAPEUTICS UK LTDAltrincham · inc. Jan 2023
All companies incorporated on 13 July 2022 · in Jul 2022.
Reminders for RHAZES PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.